Laughlin Whitney M
Known title: Chief Legal OfficerCIK: 0001992434
Laughlin Whitney M's purchase track record
Laughlin Whitney M has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/28/2024 | AMN | $50K | -3.3% | -5.1% | +10.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AMN | ▼ Sell | Tax Withholding | 122 | $4K | 9/15/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 498 | $0 | 9/15/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 202 | $0 | 1/15/2026 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 60 | $1K | 1/15/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 749 | $0 | 1/15/2026 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 223 | $4K | 1/15/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 3,537 | $0 | 1/15/2026 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 1,049 | $21K | 1/15/2026 | View on chart |
| AMN | ▲ Buy | Option Exercise | 4,976 | $0 | 10/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 1,212 | $25K | 10/15/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 483 | $0 | 9/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 118 | $2K | 9/15/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 496 | $0 | 6/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 121 | $3K | 6/15/2025 | View on chart |
| AMN | ▲ Buy | Grant | 264 | $0 | 2/21/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 79 | $2K | 2/21/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 138 | $0 | 1/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 41 | $1K | 1/15/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 196 | $0 | 1/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 59 | $2K | 1/15/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 749 | $0 | 1/15/2025 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 223 | $6K | 1/15/2025 | View on chart |
| AMN | ▲ Buy | Option Exercise | 482 | $0 | 9/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 118 | $6K | 9/15/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 256 | $0 | 8/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 63 | $3K | 8/15/2024 | View on chart |
| AMN | ▲ Buy | Open Market | 863 | $50K | 2/28/2024 | View on chart |
| AMN | ▲ Buy | Grant | 490 | $0 | 2/22/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 146 | $9K | 2/22/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 58 | $4K | 1/15/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 133 | $0 | 1/15/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 40 | $3K | 1/15/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 195 | $0 | 1/15/2024 | View on chart |
| AMN | ▲ Buy | Grant | 386 | $0 | 1/5/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 115 | $9K | 1/5/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 225 | $0 | 1/4/2024 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 67 | $5K | 1/4/2024 | View on chart |
| AMN | ▲ Buy | Option Exercise | 1,276 | $0 | 10/6/2023 | View on chart |
| AMN | ▼ Sell | Tax Withholding | 311 | $24K | 10/6/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
AMN Healthcare Maintains Outperform Rating, Target Raised to $43
Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.
AMN Healthcare Maintains Outperform Rating, Target Raised to $43. Analyst BMO Capital kept an Outperform rating on AMN Healthcare and increased its price target to $43. The company announced a third‑quarter 2026 earnings conference call scheduled for November 5. The stock trades near its $33.96 support level and carries a trailing P/E of 13.4, while analysts’ average target is $36.14.